| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 09/11/1991 | EP0445750A1 Anti-cancer-related human galactosyltransferase monoclonal antibody |
| 09/11/1991 | EP0445681A2 Preparation of a thrombin-binding substance |
| 09/11/1991 | EP0445658A1 Indoleacetic acid synthetase encoding gene |
| 09/11/1991 | EP0445646A2 DNA fragment encoding a polypeptide having nitrile hydratase activity, a transformant containing the DNA fragment and a process for the production of amides using the transformant |
| 09/11/1991 | EP0445625A1 Human monoclonal antibody against rabies virus, its production and use |
| 09/11/1991 | EP0445464A2 A new plasminogen activator derivative and a method for its manufacture |
| 09/11/1991 | EP0445460A1 A microorganism for selective production of a specific component of avermectin and a method for selective production thereof |
| 09/11/1991 | EP0445385A2 Transposon, test vectors containing the transposon and method for mutagenesis |
| 09/11/1991 | EP0445304A1 Isolated, physiologically active human thrombomodulin polypeptide |
| 09/11/1991 | EP0445227A1 Position-specific insertion vectors and method of using same |
| 09/11/1991 | EP0445218A1 Neural cell transplantation |
| 09/11/1991 | EP0445214A1 Catalytic and reactive antibodies and antibody fragments and methods for their preparation and use |
| 09/11/1991 | EP0445128A1 Proteins for fusing the sub-unit b of the choleraic toxin and heterologous antigen, and nucleic acids encoding them. |
| 09/11/1991 | EP0401362A4 Enzymatically active recombinant glucocerebrosidase |
| 09/11/1991 | EP0398944A4 Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence |
| 09/11/1991 | EP0250513B1 Process for improving the expression of a eucaryotic protein |
| 09/11/1991 | EP0188479B1 Lymphokine production and purification |
| 09/11/1991 | CN1054350A Production of fermented food products |
| 09/10/1991 | WO1991013984A2 Interleukin-4 binding proteins |
| 09/10/1991 | WO1991013910A1 Peptides stimulating cytotoxic t cells immune to hiv rt |
| 09/10/1991 | WO1991013906A1 PURIFIED gp120 COMPOSITION RETAINING NATURAL CONFORMATION |
| 09/10/1991 | US5047524 Solid phase syntheisis o nonsuelladle porous polystyrene support by phosphoramide or hydrogen phosphonate chemistry |
| 09/10/1991 | US5047519 Chain Terminating Substrates For DNA Sequencing |
| 09/10/1991 | US5047507 Diagnosis And Therapy Of Cancer |
| 09/10/1991 | US5047505 High level expression in E. coli of soluble mature HIL-1beta and derivatives with altered biological activity |
| 09/10/1991 | US5047345 Composition for isolating and purifying nucleic acid and improved method using same |
| 09/10/1991 | US5047342 Cloning and expression of T5 DNA polymerase |
| 09/10/1991 | US5047340 LAC+ saccharomyces cerevisiae |
| 09/10/1991 | US5047336 DNA sequences, recombinant DNA molecules and processes for producing mullerian inhibiting substance-like polypeptides |
| 09/10/1991 | US5047335 Process for controlling intracellular glycosylation of proteins |
| 09/10/1991 | US5047334 To produce proteins consisting of specific dna system |
| 09/10/1991 | US5047333 Method for the preparation of natural human growth hormone in pure form |
| 09/10/1991 | US5047241 Anticoagulants |
| 09/10/1991 | US5047237 Attenuated pseudorabies virus having a deletion of at least a portion of a gene encoding an antigenic, nonessential protein, vaccine containing same and methods of identifying animals vaccinated with the vaccine |
| 09/10/1991 | CA2076030A1 Interleukin-4 binding proteins |
| 09/10/1991 | CA1288774C 1,2-dialkoxy-w-trialkylammonium cationic surfactants |
| 09/10/1991 | CA1288713C Method of regenerating rice plant from protoplasts |
| 09/10/1991 | CA1288710C Amylase-negative asporogenous mutant of bacillus subtilis useful as a host in a host-vector system |
| 09/07/1991 | CA2037499A1 Preparation of a thrombin-binding substance |
| 09/06/1991 | CA2037478A1 Diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator |
| 09/05/1991 | WO1991013167A1 Identification and expression of insect steroid receptor dna sequences |
| 09/05/1991 | WO1991013159A2 Regeneration and genetic transformation of sugar beet |
| 09/05/1991 | WO1991013158A1 Protein production in yeast |
| 09/05/1991 | WO1991013156A1 Method for enhancing recovery of recombinant proteins |
| 09/05/1991 | WO1991013155A1 Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine |
| 09/05/1991 | WO1991013154A1 Improved processing of proteins |
| 09/05/1991 | WO1991013153A1 METHOD FOR OBTAINING AND PURIFYING THE CARBOXYL-TERMINAL FRAGMENT OF THE DNA POLYMERASE I OF $i(STREPTOCOCCUS PNEUNOMIAE) |
| 09/05/1991 | WO1991013150A1 Transgenic animals, cells and cell lines therefrom, and their use |
| 09/05/1991 | WO1991013149A1 Tissue plaminogen activator having fibrin specific properties |
| 09/05/1991 | WO1991013148A1 AN IgG-1 HUMAN MONOCLONAL ANTIBODY REACTIVE WITH AN HIV-1 GLYCOPROTEIN AND METHOD OF USE |
| 09/05/1991 | WO1991013086A1 Endotoxin-induced thrombosis factor which induces procoagulant activity in epithelial cells |
| 09/05/1991 | WO1991013078A1 Biosynthesis of carotenoids in genetically engineered hosts |
| 09/05/1991 | WO1991013077A1 Calcium channel compositions and methods |
| 09/05/1991 | WO1991013075A2 Method and reagent for determining specific nucleotide variations |
| 09/05/1991 | WO1991012811A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/05/1991 | WO1991011525A3 Vaccines |
| 09/05/1991 | WO1991010722A3 Chimeric immunoglobulin for cd4 receptors |
| 09/05/1991 | WO1991009973A3 C. difficile specific oligonucleotides |
| 09/05/1991 | WO1991006866A3 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 09/05/1991 | WO1991006314A3 Pharmaceutical composition having an endoproteolytic activity; a process for endoproteolytically processing (precursor) proteins and for the (micro)biological production of proteins |
| 09/05/1991 | DE4005630A1 Monoclonal antibodies against tumour-associated antigens - specifically MAB BW SCLC-1 and MAB BW SCLC-2, used in immune therapy and treatment and diagnosis of tumours |
| 09/05/1991 | CA2074523A1 Oligonucleotide therapies for modulating the effects of herpesviruses |
| 09/04/1991 | EP0445099A1 Method for purifying somatotropin monomers |
| 09/04/1991 | EP0445097A2 Method for protein N-myristoylation |
| 09/04/1991 | EP0445078A1 New use of a monoclonal antibody |
| 09/04/1991 | EP0444961A1 Her3: A novel EGF receptor homolog |
| 09/04/1991 | EP0444882A2 Plant transformation process with early identificaton of germ line transformation events |
| 09/04/1991 | EP0444787A2 Monoclonal antibodies against non-A 1C glycated hemoglobin |
| 09/04/1991 | EP0444775A1 Recombinant DNA expression vectors and DNA compounds that encode isopenicillin N epimerase activity |
| 09/04/1991 | EP0444759A1 Improved processing of proteins |
| 09/04/1991 | EP0444758A1 Method for modification of ACV synthetase and use of the modified enzyme for production of beta-lactam antibiotics |
| 09/04/1991 | EP0444664A2 Fusaric acid resistant genes |
| 09/04/1991 | EP0444639A2 A gene encoding a polypeptide having nitrile hydratase activity, a transformant containing the gene and a process for the production of amides using the transformant |
| 09/04/1991 | EP0444638A2 Process for the expression of human nerve growth factor in arthropoda frugiperda cells by infection with recombinant baculovirus |
| 09/04/1991 | EP0444560A1 Antibody specific for the tumor necrosis factor receptor |
| 09/04/1991 | EP0444181A1 C-erbb-2 external domain: gp75 |
| 09/04/1991 | EP0444149A1 High molecular weight human angiogenic factors |
| 09/04/1991 | EP0444119A1 PROCESS FOR PRODUCING cDNA. |
| 09/04/1991 | EP0444115A1 In situ suppression hybridization and uses therefor. |
| 09/04/1991 | EP0444040A1 Complete nucleotidic sequence of the complementary dna of the genomic rna of the potyvirus, genes coding for the potyvirus capside protein and application of said genes to the creation of potyvirus-resistant transgenic plants |
| 09/04/1991 | EP0263155B1 A process for obtaining chemically defined and reproducible polydeoxyribonucleotides |
| 09/04/1991 | CN1054170A Fertile transgenic corn plants |
| 09/04/1991 | CA2037446A1 Human monoclonal antibodies against rabies viruses, the production and the use thereof |
| 09/03/1991 | WO1991013166A1 Antibody constructs with enhanced binding affinity |
| 09/03/1991 | WO1991013093A1 CLONING AND PRODUCTION OF HUMAN VON WILLEBRAND FACTOR GPIb BINDING DOMAIN POLYPEPTIDES AND METHODS OF USING SAME |
| 09/03/1991 | WO1991013090A1 Improved chimeric toxins |
| 09/03/1991 | WO1991013085A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 09/03/1991 | US5045633 Expression of biologically active PDGF analogs in eucaryotic cells |
| 09/03/1991 | US5045631 Polypeptides with cell-spreading activity |
| 09/03/1991 | US5045469 Novel bacillus thuringiensis isolate denoted B. T. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 09/03/1991 | US5045463 DNA expression vector and use thereof |
| 09/03/1991 | US5045461 Method for increasing yield and nodulation by bradyrhizobium |
| 09/03/1991 | US5045460 DNA sequence encoding metallocarboxypeptidase inhibitor protein |
| 09/03/1991 | US5045455 DNA sequences, genetic engineering, blood coagulants, hemophilia |
| 09/03/1991 | US5045315 Anticoagulants |
| 09/03/1991 | CA2077446A1 Cloning and production of human von willebrand factor gpib binding domain polypeptides and methods of using same |
| 09/03/1991 | CA2077348A1 Antibody constructs with enhanced binding affinity |
| 09/03/1991 | CA2077345A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 09/03/1991 | CA2037440A1 Her3: a novel egf receptor homolog |
| 09/03/1991 | CA2025695A1 Chimeric antibody against drug-resistant cancers and process for production thereof |